Gliatamin

Choline alfoscerate

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gliatamin, covering 2025-02-24 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients [Phase 4]